Projects
- Development of an EGFR-targeting toxin with optimal biological activity, purity and construct size to facilitate tumor delivery with PCI.
- Evaluation of clinically relevant adjuvants to PCI-delivered targeted toxins.
- PCI-based targeted therapy for treatment of resistant sarcoma
- Mechanistic insight into the in vivo efficacy of targeted toxins delivered by PCI